Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
Iannaccone
S
S
Department of Neurology, San Raffaele Scientific Institute, Milan, Italy. iannaccone.sandro@hsr.it
Sferrazza
B
B
Quattrini
A
A
Smirne
S
S
Ferini-Strambi
L
L
D000328:Adult; D000368:Aged; D011146:Eczema, Dyshidrotic / Q000139:chemically induced*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000188:drug therapy*
D016756:Immunoglobulins, Intravenous